Applied Genetic Technologies Corp.

AGTC

Statistics

$4.10Share Price
$74 MMarket Cap
N/AEBIT / EV
N/AFCF / EV
N/AROIC
N/ACash ROIC
631.8%3yr Avg Revenue Growth
5.71Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

x mark Cannot calculate EBIT / Enterprise Value, company has negative EBIT.
x mark Cannot calculate Free Cash Flow / Enterprise Value, company has negative Free Cash Flow.
x mark Cannot calculate Return on Invested Capital, company has negative EBIT.
x mark Cannot calculate Cash Return on Invested Capital, company has negative Free Cash Flow.
check mark The 3 Year Average Revenue Growth Value of 631.8% ranks as Very High.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 5.71.

Company Description

Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
purple wand New Stocks Added!
orange wand New Stocks Added!